This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Sysmex Corporation. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Saori Otsuka: Innovator in Leukocyte Classification
Introduction
Saori Otsuka is a notable inventor based in Kusatsu, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the classification and counting of leukocytes. His innovative work has the potential to enhance the accuracy of blood analysis and improve patient outcomes.
Latest Patents
Otsuka holds a patent for a "Method for classifying/counting leukocytes, reagent kit for classifying leukocytes, and reagent for classifying leukocytes." This invention provides a method that allows for the classification and counting of normal leukocytes, as well as the discrimination between blast cells and atypical lymphocytes. The patent also includes a reagent kit and reagent specifically designed for classifying and counting leukocytes in biological samples.
Career Highlights
Saori Otsuka is associated with Sysmex Corporation, a leading company in the field of medical diagnostics. His work at Sysmex has allowed him to focus on developing innovative solutions that address critical needs in healthcare.
Collaborations
Otsuka has collaborated with notable colleagues, including Kazuki Hatcho and Toshihiro Mizukami. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Saori Otsuka's contributions to leukocyte classification represent a significant advancement in medical diagnostics. His innovative methods and collaborative efforts continue to pave the way for improved healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
